Post by
antigua1987 on Jul 06, 2021 2:38pm
Oct 2009 IPO ...
2.40$Cad (rev split adjusted). not complaining - just a fact. /s.
operating spend since ipo: 20,000,000$/yr @ 12 yrs = 240,000,000$.
annual revenue 2020: 100,000$.
and after all this time we're praying that tiny sample of 6/7 patient success translates in dlbcl ph2. whose 1st result maybe sees daylight june2022. That's a lot of company skating in the meantime.
c'mon man.